These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1113 related items for PubMed ID: 9708933

  • 1. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P, Daures JP, Thezenas S, Guilleux F, Rouanet P, Grenier J.
    Cancer; 1998 Aug 15; 83(4):698-705. PubMed ID: 9708933
    [Abstract] [Full Text] [Related]

  • 2. A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma.
    Pujol P, Daures JP, Brouillet JP, Chang S, Rouanet P, Bringer J, Grenier J, Maudelonde T.
    Cancer; 2001 May 15; 91(10):1854-61. PubMed ID: 11346866
    [Abstract] [Full Text] [Related]

  • 3. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
    Hale GE, Hughes CL, Burger HG, Robertson DM, Fraser IS.
    Menopause; 2009 May 15; 16(1):50-9. PubMed ID: 18978637
    [Abstract] [Full Text] [Related]

  • 4. Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer.
    Pujol P, Daurès JP, Brouillet JP, Maudelonde T, Rochefort H, Grenier J.
    Br J Cancer; 1999 Feb 15; 79(5-6):909-14. PubMed ID: 10070889
    [Abstract] [Full Text] [Related]

  • 5. Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels.
    Saez S, Martin PM, Chouvet CD.
    Cancer Res; 1978 Oct 15; 38(10):3468-73. PubMed ID: 688231
    [Abstract] [Full Text] [Related]

  • 6. [Study on serum inhibin concentrations in women during menopausal transition].
    Zhang YW, Chen WL, Yu Q, Song YH, Zhou J, Zhang DY.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb 15; 38(2):98-101. PubMed ID: 12783698
    [Abstract] [Full Text] [Related]

  • 7. [Features of breast ultrasound image and its correlation with estradiol and progesterone level in different phases of menstrual cycle in normal women].
    Zhou YZ, Jiang YX, Sun Q, Zhang SQ, Zhang Y, Chen FL, Lin SQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec 15; 23(6):609-13. PubMed ID: 12901108
    [Abstract] [Full Text] [Related]

  • 8. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun 15; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 9. Menstrual cycle and hormone receptor status in breast cancer patients.
    Atalay C, Kanliöz M, Altinok M.
    Neoplasma; 2002 Jun 15; 49(4):278. PubMed ID: 12382029
    [Abstract] [Full Text] [Related]

  • 10. Variations in steroid hormone receptor content throughout age and menopausal periods, and menstrual cycle in breast cancer patients.
    Nikolić-Vukosavljević D, Vasiljević N, Branković-Magić M, Polić D.
    Neoplasma; 1996 Jun 15; 43(3):163-9. PubMed ID: 8841503
    [Abstract] [Full Text] [Related]

  • 11. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM, Viale G, Mastropasqua MG, Maiorano E, Golouh R, Carbone A, Brown B, Suurküla M, Langman G, Mazzucchelli L, Braye S, Grigolato P, Gelber RD, Castiglione-Gertsch M, Price KN, Coates AS, Goldhirsch A, Gusterson B, International Breast Cancer Study Group.
    J Natl Cancer Inst; 2006 Nov 01; 98(21):1571-81. PubMed ID: 17077359
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
    Thorpe SM, Rose C, Rasmussen BB, Mouridsen HT, Bayer T, Keiding N.
    Cancer Res; 1987 Nov 15; 47(22):6126-33. PubMed ID: 3664512
    [Abstract] [Full Text] [Related]

  • 13. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma.
    Spona J, Ulm R, Bieglmayer C, Husslein P.
    Gynecol Obstet Invest; 1979 Nov 15; 10(2-3):71-80. PubMed ID: 535775
    [Abstract] [Full Text] [Related]

  • 14. Age effects of follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women.
    Reame NE, Kelche RP, Beitins IZ, Yu MY, Zawacki CM, Padmanabhan V.
    J Clin Endocrinol Metab; 1996 Apr 15; 81(4):1512-8. PubMed ID: 8636360
    [Abstract] [Full Text] [Related]

  • 15. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.
    J Natl Cancer Inst; 2006 Oct 04; 98(19):1406-15. PubMed ID: 17018787
    [Abstract] [Full Text] [Related]

  • 16. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.
    Breast Cancer Res Treat; 2009 Jul 04; 116(1):131-43. PubMed ID: 18668363
    [Abstract] [Full Text] [Related]

  • 17. Timing of breast cancer surgery within the menstrual cycle: tumor proliferative activity, receptor status and short-term clinical outcome.
    Mangia A, De Lena M, Barletta A, Marzullo F, Attolico M, Stea B, Petroni S, Labriola A, Cellamare G, Digiesi G, Altieri R, Schittulli F, Paradiso A.
    J Exp Clin Cancer Res; 1998 Sep 04; 17(3):317-23. PubMed ID: 9894769
    [Abstract] [Full Text] [Related]

  • 18. Hormone receptors and disease-free survival in breast cancer: impact of increasing threshold levels.
    Di Fronzo G, Coradini D, Cappelletti V, Miodini P, Granata G, Schwartz M, Panko WB.
    Anticancer Res; 1990 Sep 04; 10(6):1699-705. PubMed ID: 2285244
    [Abstract] [Full Text] [Related]

  • 19. Serum hormones in human breast cancer subjects.
    Krishnamoorthy G, Govindarajulu P, Ramalingam V.
    Neoplasma; 1989 Sep 04; 36(2):221-31. PubMed ID: 2497392
    [Abstract] [Full Text] [Related]

  • 20. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, Schnall M, Alavi A.
    Cancer; 2008 Mar 01; 112(5):995-1000. PubMed ID: 18098228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.